Search results for "Arterial hypertension"

showing 10 items of 69 documents

RELATIONSHIP BETWEEN URIC ACID AND RENAL DAMAGE IN HYPERTENSIVE PATIENTS: WHICH ROLE FOR RENAL HAEMODYNAMICS

2016

Settore MED/14 - NefrologiaSettore MED/09 - Medicina InternaURIC ACIDRENAL FUNCTIONARTERIAL HYPERTENSION
researchProduct

BILATERAL RENAL ARTERY STENOSIS IN A HYPERTENSIVE LUPUS PATIENT WITHOUT RENAL DYSFUNCTION: A CASE REPORT

2014

Systemic lupus erythematosus (SLE) is associated with a high prevalence of atherosclero-sis and an enhanced cardiovascular mortality. In adult subjects, several studies have shown the coexistence of SLE and renal artery stenosis, most of them with unilateral in-volvement or with renal dysfunction. We observed a 62-year-old man with SLE and a 10-year history of moderate-to-severe hy-pertension who was admitted to our hospital because of uncontrolled blood pressure val-ues (152/95 mmHg), despite drug therapy. No signs of renal impairment were evident. After an initial physical examination, which presented a periumbilical bruit, a renal ultra-sound was performed with evidence of bilateral rena…

Settore MED/14 - Nefrologiaarterial hypertensionSettore MED/16 - ReumatologiaatherosclerosiSettore MED/09 - Medicina InternaSystemic lupus erythematosuSettore MED/11 - Malattie Dell'Apparato Cardiovascolarerenal artery stenosi
researchProduct

[OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS

2016

OBJECTIVE: Left ventricular hypertrophy is common in hypertensive patients. In these subjects increased oxidative stress has been observed. Our aim was to evaluate the association of biomarkers of both oxidative stress and inflammation with markers of cardiovascular damage in a large group of hypertensives with different stages of renal function. DESIGN AND METHOD: In 517 hypertensives we analyzed left ventricular mass indexed for body surface area, and we assayed plasma levels of 8-isoprostaglandin F2alpha and high sensitivity C reactive protein. RESULTS: Multivariate analysis carried out considering left ventricular mass as dependent variable, and including 8-isoprostaglandin F2alpha, hig…

Settore MED/14 - Nefrologiamedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industrymedicine.disease_causeLEFT VENTRICULAR HYPERTROPHY - ARTERIAL HYPERTENSION - OXIDATIVE STRESSSettore MED/11 - Malattie Dell'Apparato CardiovascolareCardiac hypertrophyInternal medicineInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessOxidative stressJournal of Hypertension
researchProduct

Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hyperten…

2012

This article is aimed at addressing the current state of the art in epidemiology, pathophysiology, diagnostic procedures and treatment options for appropriate management of obstructive sleep apnea (OSA) in cardiovascular (particularly hypertensive) patients, as well as for the management of cardiovascular diseases (particularly arterial hypertension) in OSA patients. The present document is the result of the work done by a panel of experts participating in the European Union COST (COoperation in Scientific and Technological research) ACTION B26 on OSA, with the endorsement of the European Respiratory Society (ERS) and the European Society of Hypertension (ESH). These recommendations are par…

Societies Scientificmedicine.medical_specialtyPhysiologyArterial hypertension continuous positive airway pressure treatment guidelines hypertension treatment obstructive sleep apnoeaComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioCheyne–Stokes respirationEpidemiologyarterial hypertension continuous positive airway pressure treatment guidelines hypertension treatment obstructive sleep apneaInternal MedicinemedicineHumansmedia_common.cataloged_instanceEuropean unionIntensive care medicinemedia_commonSleep Apnea Obstructivebusiness.industrySleep apneaMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareComorbidityEuropeSurvival RateObstructive sleep apneaBlood pressureHypertensionPractice Guidelines as TopicPosition papermedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Characterizing Diagnostic Inertia in Arterial Hypertension With a Gender Perspective in Primary Care

2022

Background and ObjectivesSubstantial evidence shows that diagnostic inertia leads to failure to achieve screening and diagnosis objectives for arterial hypertension (AHT). In addition, different studies suggest that the results may differ between men and women. This study aimed to evaluate the differences in diagnostic inertia in women and men attending public primary care centers, to identify potential gender biases in the clinical management of AHT.Study Design/Materials and MethodsCross-sectional descriptive and analytical estimates were obtained nested on an epidemiological ambispective cohort study of patients aged ≥30 years who attended public primary care centers in a Spanish region …

arterial hypertensionequityprimary careArtèriesdiagnostic inertiaMalaltiesgenderDones MalaltiesCardiology and Cardiovascular MedicineFrontiers in Cardiovascular Medicine
researchProduct

RELATIONSHIP BETWEEN ASYMPTOMATIC HYPERURICEMIA AND RENAL FUNCTION DECLINE IN HYPERTENSIVE SUBJECTS.

2013

Introduction: It is well known that the deposition of uric acid crystals exert direct toxic effect on the renal parenchyma and vasculature. Both experimental and some clinical studies suggest the possibility that an increased uric acid level can lead to kidney disease even without deposition of uric acid crystals. However, other studies yielded conflicting results, especially regarding the role of uric acid in the progression of established kidney disease. Aim: To evaluate retrospectively the relationship between asymptomatic hyperuricemia and renal function decline in non-gouty hypertensive patients. Methods: We enrolled 97 hypertensive subjects, 48 with chronic kidney diseases (CKD) and 4…

arterial hypertensionkidney diseaserenal functionrenal function declineasymptomatic hyperuricemiaUric acidarterial hypertension.
researchProduct

The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage

2007

High blood pressure is often associated with various metabolic abnormalities, including abdominal obesity, dyslipidemia, elevated plasma glucose, and insulin resistance, which are the main features of the metabolic syndrome. The metabolic syndrome is extremely common worldwide. This high prevalence is of considerable concern because several studies suggest that the metabolic syndrome carries an increased risk for cardiovascular events. Several lines of evidence seem to indicate that the metabolic syndrome is associated with an increased prevalence of preclinical cardiovascular and renal changes, such as left ventricular hypertrophy, microalbuminuria, impaired aortic elasticity, and early ca…

arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismLeft ventricular hypertrophyRisk AssessmentInsulin resistanceRisk Factorstarget organ damageInternal medicinePrevalenceInternal MedicinemedicineHumansAbdominal obesityReview Paperbusiness.industrymedicine.diseaseMetabolic syndromeBlood pressureCardiovascular DiseasesHypertensionCardiologyMicroalbuminuriaMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessDyslipidemiaThe Journal of Clinical Hypertension
researchProduct

Bilateral double renal arteries and bilateral renal veins. A color-Doppler sonographic finding in a patient with arterial hypertension

2010

arterial hypertensionrenal arteriecolor-Doppler
researchProduct

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Ass…

2017

International audience; : Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to pr…

cardiovascular riskRiskarterial hypertensionmedicine.medical_specialtyNoninvasive imagingPhysiologyPopulation030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicinetarget organ damageInternal medicineInternal MedicineHumansMedicineIn patient030212 general & internal medicineAdverse effectIntensive care medicineeducationSocieties MedicalCardiovascular mortalitySubclinical infectionCardiac Imaging Techniqueeducation.field_of_studybusiness.industrynoninvasive cardiovascular imagingTarget organ damage3. Good healthCardiac Imaging TechniquesHypertensionPractice Guidelines as TopicCardiology[SDV.IB]Life Sciences [q-bio]/Bioengineeringmedicine.symptomCardiology and Cardiovascular MedicinebusinessprognosiHuman
researchProduct

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

2017

International audience; Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology …

cardiovascular riskmedicine.medical_specialtyarterial hypertension[SDV]Life Sciences [q-bio]Population030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineInternal medicinetarget organ damageMedicineRadiology Nuclear Medicine and imagingIn patient030212 general & internal medicineAdverse effecteducationnon-invasive cardiovascular imagingSubclinical infectioneducation.field_of_studybusiness.industryNon invasiveGeneral MedicineTarget organ damage3. Good healthRisk stratificationCardiologyprognosismedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct